Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (36 ops.)
Latest filing published 03 Mar 2026 for Abbott Laboratories, €652k.
Filing timeline
BuySaleDaniel Gesua Sive Salvadori
Insider track record
Disclosed buys
0
Disclosed sells
36
Signal history
Daniel Gesua Sive Salvadori: trading record in brief
At Abbott Laboratories, Daniel Gesua Sive Salvadori files as Executive Vice President. The record holds no purchase. It has 78 filings, among them 36 sales worth EUR 40.7 million (median EUR 109,866), 13 option exercises, 28 share grants and 1 filing of another kind.
Three sales stand out: December 23, 2021 (EUR 7,229,437), December 13, 2021 (EUR 6,563,922) and June 26, 2019 (EUR 5,243,191).
The busiest year is 2017, with 22 filings. From 2021 to 2024 the record stays at 3 a year, then rises to 5 in 2025 and 3 in 2026. Over the last twelve months there are 4 filings, one of them a sale. Filings are published a median of 2 days after the trade.
Within 30 days of colleagues at Abbott Laboratories, Salvadori has 19, 15 and 14 own market trades, in that order. All on the same side. The colleagues, in the same order: Brian J. Blaser, Sharon J. Bracken and Hubert L. Allen.
Companies and markets linked to Daniel Gesua Sive Salvadori
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations78 total
6,615 shares@ US$116.269.2% of flowCommon shares without par valueSEC:0001620564-26-000007:0
885 shares@ US$115.581.2% of flowCommon shares without par valueSEC:0001620564-26-000007:1
21,644 shares0Common shares without par valueSEC:0001620564-26-000002:0
1,536 shares@ US$123.282.3% of flowCommon shares without par valueSEC:0001620564-25-000009:0
8,462 shares@ US$135.8715.6% of flowCommon shares without par valueSEC:0001415889-25-006789:0
16,534 shares0Common shares without par valueSEC:0001415889-25-005918:0
23,771 shares@ US$128.504.3% of flowCommon shares without par valueSEC:0001415889-25-002584:1
23,771 shares@ US$38.4012.3% of flowCommon shares without par valueSEC:0001415889-25-002584:0
963 shares@ US$118.500.2% of flowCommon shares without par valueSEC:0001415889-24-006417:1
8,874 shares@ US$120.0513.9% of flowCommon shares without par valueSEC:0001415889-24-006417:0
15,673 shares0Common shares without par valueSEC:0001415889-24-005109:0
1,085 shares@ US$100.700.2% of flowCommon shares without par valueSEC:0001415889-23-003916:1
9,002 shares@ US$99.7711.9% of flowCommon shares without par valueSEC:0001415889-23-003916:0
17,700 shares0Common shares without par valueSEC:0001415889-23-003060:0
1,550 shares@ US$118.170.2% of flowCommon shares without par valueSEC:0001415889-22-002200:1
10,551 shares@ US$122.4116.3% of flowCommon shares without par valueSEC:0001415889-22-002200:0
23,919 shares0Common shares without par valueSEC:0001415889-22-001744:0
31,229 shares@ US$44.401.9% of flowCommon shares without par valueSEC:0001415889-21-006263:1
58,501 shares@ US$140.0011.1% of flowCommon shares without par valueSEC:0001415889-21-006263:2
23,771 shares@ US$38.4011.4% of flowCommon shares without par valueSEC:0001415889-21-006263:0
23,771 shares@ US$38.401.2% of flowCommon shares without par valueSEC:0001415889-21-005967:1
31,229 shares@ US$44.401.9% of flowCommon shares without par valueSEC:0001415889-21-005967:2
55,000 shares@ US$135.0010.1% of flowCommon shares without par valueSEC:0001415889-21-005967:3
3,499 shares@ US$135.005.9% of flowCommon shares without par valueSEC:0001415889-21-005967:0
12,596 shares@ US$121.581.9% of flowCommon shares without par valueSEC:0001415889-21-001212:0
25 of 78 declarations
